Hambrecht & Quist Capital Management
Latest statistics and disclosures from Tekla Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are CELG, GILD, BIIB, AMGN, VRTX, and represent 27.15% of Tekla Capital Management's stock portfolio.
- Added to shares of these 10 stocks: MRK (+$17.62M), Nevro (+$14.49M), Clovis Oncology (+$14.12M), NVS (+$12.51M), BIIB (+$12.16M), CELG (+$11.69M), SGEN (+$11.57M), Ra Pharmaceuticals (+$7.42M), Dermira (+$6.46M), Wright Medical Group Nv (+$5.90M).
- Started 14 new stock positions in Ra Pharmaceuticals, Avexis, Argenx Se, Express Scripts Holding, Trillium Therapeutics, Inc. Cmn, Entellus Medical Cm, Clovis Oncology, Wright Medical Group Nv, SGEN, Ovid Therapeutics. Nevro, Verona Pharma Plc ads, Nabriva Therapeutics, Syndax Pharmaceuticals.
- Reduced shares in these 10 stocks: VRTX (-$30.34M), , TMO (-$15.51M), PFE (-$11.31M), , ALNY (-$10.29M), Care Cap Properties (-$9.27M), Jazz Pharmaceuticals (-$8.94M), Galapagos Nv-spon (-$7.40M), ABC (-$7.17M).
- Sold out of its positions in Beigene, Care Cap Properties, EW, Forward Pharma A/s, Grifols S A Sponsored Adr R, HALO, MOH, Nabriva Therapeutics Ag, XLV.
- Tekla Capital Management was a net seller of stock by $20.01M.
- Tekla Capital Management has $2.70B in assets under management (AUM), growing by 4.66%.
Companies in the Tekla Capital Management portfolio as of June 2017 quarter
| Company (Ticker) | Portfolio Weight | Share Count | Change in Shares | Price |
|---|---|---|---|---|
| Celgene Corporation (CELG) | 7.01 | 1.46M | +6% | 129.87 |
| Gilead Sciences (GILD) | 6.63 | 2.53M | 70.78 | |
| Biogen Idec (BIIB) | 5.33 | 529774 | +9% | 271.36 |
| Amgen (AMGN) | 4.37 | 684824 | 172.23 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.81 | 798053 | -22% | 128.87 |
| Johnson & Johnson (JNJ) | 3.50 | 714362 | 132.29 | |
| Merck & Co (MRK) | 3.50 | 1.47M | +22% | 64.09 |
| Regeneron Pharmaceuticals (REGN) | 3.41 | 187666 | 491.14 | |
| Alexion Pharmaceuticals (ALXN) | 3.38 | 750905 | -5% | 121.67 |
| Incyte Corporation (INCY) | 3.23 | 693275 | 125.91 | |
| Allergan | 2.80 | 310610 | 243.09 | |
| Mylan Nv | 2.31 | 1.60M | +3% | 38.82 |
| UnitedHealth (UNH) | 2.11 | 307476 | 185.42 | |
| Abbott Laboratories (ABT) | 2.08 | 1.15M | 48.61 | |
| Medtronic | 1.91 | 580326 | -5% | 88.75 |
| Illumina (ILMN) | 1.79 | 278960 | -6% | 173.52 |
| BioMarin Pharmaceutical (BMRN) | 1.69 | 501745 | 90.82 | |
| Jazz Pharmaceuticals | 1.58 | 273916 | -17% | 155.50 |
| Shire (SHPGY) | 1.54 | 252113 | +8% | 165.27 |
| Eli Lilly & Co. (LLY) | 1.50 | 493100 | 82.30 | |
| Teva Pharmaceutical Industries (TEVA) | 1.25 | 1.02M | 33.22 | |
| CVS Caremark Corporation (CVS) | 1.23 | 411891 | 80.46 | |
| Novartis AG (NVS) | 1.23 | 398662 | +60% | 83.47 |
| Humana (HUM) | 1.11 | 124781 | -18% | 240.62 |
| Pfizer (PFE) | 1.01 | 810087 | -29% | 33.59 |
| Neurocrine Biosciences (NBIX) | 0.96 | 562467 | +26% | 46.00 |
| Thermo Fisher Scientific (TMO) | 0.90 | 139120 | -38% | 174.47 |
| AmerisourceBergen (ABC) | 0.89 | 254887 | -22% | 94.53 |
| McKesson Corporation (MCK) | 0.87 | 142800 | +26% | 164.54 |
| iShares NASDAQ Biotechnology Index (IBB) | 0.87 | 75970 | -2% | 310.08 |
| IDEXX Laboratories (IDXX) | 0.79 | 132352 | 161.42 | |
| AstraZeneca (AZN) | 0.70 | 550600 | +18% | 34.09 |
| Puma Biotechnology Inc Common Stock | 0.66 | 202537 | -22% | 87.40 |
| SPDR S&P; Biotech (XBI) | 0.65 | 226460 | 77.18 | |
| Sarepta Therapeutics | 0.64 | 511600 | 33.71 | |
| GlaxoSmithKline (GSK) | 0.57 | 359000 | 43.12 | |
| Centene Corporation (CNC) | 0.57 | 192600 | +33% | 79.88 |
| Omega Healthcare Investors (OHI) | 0.56 | 458616 | 33.02 | |
| Nevro | 0.54 | 194621 | NEW | 74.43 |
| Pieris Pharmaceuticals | 0.53 | 2.84M | -27% | 5.06 |
| CIGNA Corporation (CI) | 0.52 | 83900 | 167.39 | |
| Clovis Oncology | 0.52 | 150800 | NEW | 93.63 |
| Exelixis (EXEL) | 0.50 | 551647 | 24.63 | |
| Zimmer Holdings (ZMH) | 0.49 | 102300 | 128.40 | |
| Senior Housing Properties Trust (SNH) | 0.49 | 646554 | 20.44 | |
| Sabra Health Care REIT (SBRA) | 0.49 | 550990 | 24.10 | |
| Welltower Inc 6.50% pfd prepet | 0.49 | 200000 | 66.26 | |
| Charles River Laboratories (CRL) | 0.48 | 127100 | 101.15 | |
| Medical Properties Trust (MPW) | 0.48 | 1.01M | 12.87 | |
| Paratek Pharmaceuticals | 0.48 | 533000 | -30% | 24.10 |
| Ventas (VTR) | 0.45 | 175991 | 69.48 | |
| Seattle Genetics (SGEN) | 0.43 | 223700 | NEW | 51.74 |
| Acadia Healthcare | 0.42 | 231200 | 49.38 | |
| Dermira | 0.42 | 386900 | +134% | 29.14 |
| Akorn (AKRX) | 0.41 | 327735 | 33.54 | |
| Physicians Realty Trust | 0.40 | 530672 | 20.14 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 0.39 | 13.00M | 0.81 | |
| Bristol Myers Squibb (BMY) | 0.38 | 186500 | 55.72 | |
| Endo International | 0.38 | 914548 | 11.17 | |
| Novo Nordisk A/S (NVO) | 0.35 | 217300 | +161% | 42.89 |
| Alnylam Pharmaceuticals (ALNY) | 0.34 | 114966 | -52% | 79.76 |
| Sanofi-Aventis SA (SNY) | 0.32 | 179900 | -41% | 47.91 |
| HCA HOLDINGS Inc | 0.31 | 95232 | +50% | 87.20 |
| Cellectis S A sponsored ads | 0.30 | 310250 | 25.82 | |
| Cytomx Therapeutics | 0.30 | 530092 | 15.50 | |
| Ultragenyx Pharmaceutical | 0.29 | 127308 | +44% | 62.11 |
| Valeant Pharmaceuticals Int (VRX) | 0.28 | 430000 | +123% | 17.30 |
| Pra Health Sciences | 0.28 | 102000 | 75.01 | |
| Merus N V | 0.28 | 479150 | 15.85 | |
| Tetraphase Pharmaceuticals | 0.27 | 1.00M | 7.13 | |
| Sage Therapeutics | 0.27 | 90480 | 79.64 | |
| Ra Pharmaceuticals | 0.27 | 395818 | NEW | 18.74 |
| LTC Properties (LTC) | 0.26 | 136212 | 51.39 | |
| Flamel Technologies Sa | 0.26 | 624288 | 11.03 | |
| Karyopharm Therapeutics | 0.25 | 756679 | +25% | 9.05 |
| Diplomat Pharmacy | 0.25 | 461712 | +254% | 14.80 |
| Adaptimmune Therapeutics | 0.24 | 1.47M | 4.49 | |
| Dex (DXCM) | 0.23 | 84500 | +18% | 73.15 |
| Cardinal Health (CAH) | 0.22 | 76600 | 77.92 | |
| Universal Health Services (UHS) | 0.22 | 48076 | 122.08 | |
| Tenet Healthcare Corporation stock | 0.22 | 313440 | +90% | 19.34 |
| Wright Medical Group Nv | 0.22 | 214781 | NEW | 27.49 |
| United Therapeutics Corporation (UTHR) | 0.21 | 43961 | 129.73 | |
| New Senior Inv Grp | 0.21 | 567997 | 10.05 | |
| Entellus Medical Cm | 0.21 | 341471 | NEW | 16.56 |
| Express Scripts Holding | 0.20 | 84500 | NEW | 63.83 |
| Natera | 0.20 | 485758 | -44% | 10.86 |
| Ovid Therapeutics | 0.19 | 535824 | NEW | 9.76 |
| Egalet Corporation note 5.50% 4/1/20 | 0.17 | 7.00M | 0.64 | |
| Myovant Sciences | 0.17 | 400000 | 11.70 | |
| Epizyme | 0.16 | 281000 | -22% | 15.10 |
| Foamix Pharmaceuticals Ltd shs | 0.16 | 930398 | 4.64 | |
| Allergan Plc pfd conv ser a | 0.16 | 5000 | 868.00 | |
| Global Blood Therapeutics In | 0.13 | 125000 | -27% | 27.35 |
| Retrophin | 0.12 | 167949 | 19.39 | |
| Ardelyx | 0.12 | 639370 | 5.10 | |
| Dynavax Technologies | 0.12 | 345050 | 9.65 | |
| Innoviva | 0.12 | 248803 | 12.80 | |
| Verona Pharma Plc ads | 0.12 | 275000 | NEW | 11.68 |
| Affimed Therapeutics B V | 0.11 | 1.41M | 2.05 | |
| Momenta Pharmaceuticals (MNTA) | 0.10 | 152900 | -69% | 16.90 |
| Accelr8 Technology | 0.10 | 100000 | 27.35 | |
| Mallinckrodt Pub | 0.10 | 61900 | 44.81 | |
| Perrigo Company | 0.10 | 37300 | 75.52 | |
| Syndax Pharmaceuticals | 0.10 | 200000 | NEW | 13.97 |
| Healthcare Realty Trust Incorporated (HR) | 0.09 | 68000 | 34.15 | |
| Community Health Systems (CYH) | 0.08 | 203935 | 9.96 | |
| Dbv Technologies S A | 0.08 | 63800 | -2% | 35.71 |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.08 | 286472 | 7.50 | |
| Impax Laboratories (IPXL) | 0.07 | 124335 | 16.10 | |
| Nanostring Technologies | 0.07 | 113500 | 16.54 | |
| Acceleron Pharma | 0.07 | 59654 | +9% | 30.39 |
| Horizon Pharma | 0.07 | 162900 | 11.87 | |
| Trillium Therapeutics, Inc. Cmn | 0.07 | 500000 | NEW | 3.96 |
| Arca Biopharma | 0.07 | 811227 | 2.45 | |
| Amicus Therapeutics (FOLD) | 0.06 | 160730 | -61% | 10.07 |
| Uniqure Nv shs | 0.06 | 241021 | 6.19 | |
| Juno Therapeutics | 0.06 | 56900 | 29.89 | |
| Welltower Inc Com reit | 0.06 | 21400 | 74.86 | |
| Argenx Se | 0.06 | 75000 | NEW | 21.21 |
| Nabriva Therapeutics | 0.06 | 149334 | NEW | 11.23 |
| HCP (HCP) | 0.05 | 45500 | 31.96 | |
| Bluebird Bio | 0.05 | 13273 | -73% | 105.03 |
| Healthcare Tr Amer Inc cl a | 0.05 | 46000 | 31.11 | |
| Coherus Biosciences | 0.05 | 90000 | 14.36 | |
| Spark Therapeutics | 0.05 | 24300 | 59.75 | |
| Galapagos Nv-spon | 0.05 | 19000 | -83% | 76.53 |
| GenMark Diagnostics (GNMK) | 0.04 | 93349 | 11.83 | |
| Xenon Pharmaceuticals | 0.04 | 350000 | 3.15 | |
| Bellicum Pharma | 0.03 | 60000 | 11.68 | |
| Avexis | 0.03 | 10000 | NEW | 82.20 |
| Allscripts Healthcare Solutions (MDRX) | 0.02 | 47300 | 12.77 | |
| Novavax (NVAX) | 0.02 | 571000 | 1.15 | |
| Alliqua | 0.02 | 1.65M | 0.37 | |
| Xencor | 0.02 | 20000 | 21.10 | |
| Auris Med Hldg Ag | 0.02 | 774504 | 0.72 | |
| Flex Pharma | 0.02 | 159549 | 3.85 | |
| Global Medical Reit, Inc. stock | 0.02 | 73400 | 8.94 | |
| Intellia Therapeutics Inc Com stock | 0.02 | 28000 | -61% | 16.00 |
| Celldex Therapeutics (CLDX) | 0.01 | 105800 | 2.47 | |
| Rmr Group Inc cl a | 0.01 | 7441 | 48.65 | |
| Abbvie | 0.00 | 213 | +36% | 70.42 |
| Zafgen | 0.00 | 13307 | 3.53 | |
| Quorum Health | 0.00 | 23725 | 4.13 |
Download CSV 
Past 13F-HR SEC Filings by Tekla Capital Management
- Tekla Capital Management 2017 Q1 filed May 12, 2017
- Tekla Capital Management 2016 Q4 filed Feb. 13, 2017
- Tekla Capital Management 2016 Q3 filed Nov. 14, 2016
- Tekla Capital Management 2016 Q2 filed Aug. 12, 2016
- Tekla Capital Management 2016 Q1 filed May 9, 2016
- Tekla Capital Management 2015 Q4 filed Feb. 9, 2016
- Tekla Capital Management 2015 Q3 filed Nov. 13, 2015
- Tekla Capital Management 2015 Q2 filed Aug. 12, 2015
- Tekla Capital Management 2015 Q1 filed May 6, 2015
- Tekla Capital Management 2014 Q4 filed Jan. 30, 2015
- Tekla Capital Management 2014 Q2 filed Aug. 5, 2014
- Tekla Capital Management 2014 Q1 filed May 13, 2014
- Tekla Capital Management 2013 Q4 filed Jan. 28, 2014
- Tekla Capital Management 2013 Q3 filed Oct. 30, 2013
- Tekla Capital Management 2013 Q2 filed July 31, 2013
- Tekla Capital Management 2013 Q1 filed April 26, 2013
- Tekla Capital Management 2012 Q4 filed Feb. 1, 2013
- Tekla Capital Management 2012 Q3 filed Oct. 19, 2012
- Tekla Capital Management 2012 Q2 filed July 31, 2012